CBD Stocks

The Best CBD Penny Stock to Buy on New FDA Study

The Best CBD Penny Stock to Buy on New FDA Study

By Mike Stenger, Associate Editor, Money Morning • June 11, 2020 Great news for the CBD industry this week is even better news for penny stock investors. The FDA is making progress on CBD research. And we know one of the best CBD penny stocks to buy as it happens....

CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge

You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.

UK’s CBD market faces reckoning

UK’s CBD market faces reckoning

TipRanks These 2 EV Stocks Have Over 100% Upside on the Horizon, Says Analyst They say that politics are downstream from culture – but so are the stock markets. And sometimes, culture informs our investment decisions in ways that we could never have predicted just a...

Cronus Group Stock is Cash Rich Cannabis Play

Cannabinoid products producer Cronus Group (NASDAQ: CRON) stock has fallen over (-30%) from its $15.83 year-to-date (YTD) highs reached on Feb. 10, 2021 with the Nasdaq sell-off. To be fair, the whole cannabis group including Canada-based Tilray (NASDAQ: TLRY), Canopy...

CBDA Proves to be a Star Ingredient of CBD

CBDA Proves to be a Star Ingredient of CBD

BEND, Ore., June 9, 2020 /PRNewswire/ — Rooted Hemp, a small-batch CBD company, is ahead of the curve when it comes to CBD products, which is why it’s no surprise they are embracing new research that shows CBDA to be a star ingredient in full-spectrum...

Be Cautious When Buying Faltering Canopy Stock

Be Cautious When Buying Faltering Canopy Stock

Investors reacted swiftly and angrily when Canopy Growth (NYSE:CGC) reported quarterly results. The company’s revenue grew by just 14.7% while losses worsened by 243.3% to 1.303 Canadian dollars ($970 million). Is CGC stock still the leading cannabis firm? Source:...